The Only Specialized Global Intellectual Property News Agency
A Member of Talal Abu-Ghazaleh Organization

banner

Citius Pharmaceuticals Announces US Patent Office Publication of Enhanced Stability Patent Application Covering Mino-Lok™

22-Jun-2017 | Source : AG-IP News | Visits : 658
CRANFORD, N.J. - Citius Pharmaceuticals Inc., a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced in a press release it has received notification from MD Anderson Cancer Center that US Patent Application (US 2017/0151373 A1) has been published by the US Patent Office, date of publication June 1, 2017: the application was originally filed on November 4, 2016. 

The patent invention overcomes limitations in mixing antimicrobial solutions in which components may precipitate because of physical and/or chemical factors, thus limiting the stability of the post-mix solutions. Citius holds the exclusive worldwide license  which provides access to this patented technology for development and commercialization of Mino-Lok.

"The stability of the Mino-Lok solution post mixing was limited to a time period of about 24 hours prior to use," said Mr. Myron Holubiak, President and CEO of Citius Pharmaceuticals. "We recognized that it would be beneficial for product acceptance and utility if improvement in the post-mix stability could be achieved; this would enable standard pharmacy process to be employed in the delivery of Mino-Lok to the patient, and  would allow for several days storage of ready-to-use Mino-Lok. Aside from also offering greater intellectual property protection if the patent is granted, the post-mix stability of Mino-Lok is important to the potential world market for the product. Citius is committed to developing Mino-Lok as a cost saving therapy in all countries, as we believe Mino-Lok should find receptive markets worldwide." 

Citius is currently recruiting sites for phase 3 trials of Mino-Lok in the United States. There are currently no approved therapies to salvage infected CVCs. 
 
share



Related Articles